Ponti Giovanni, Losi Lorena, Di Gregorio Carmela, Roncucci Luca, Pedroni Monica, Scarselli Alessandra, Benatti Piero, Seidenari Stefania, Pellacani Giovanni, Lembo Luigi, Rossi Giuseppina, Marino Massimiliano, Lucci-Cordisco Emanuela, Ponz de Leon Maurizio
Division of Internal Medicine, University of Modena and Reggio Emilia, Modena, Italy.
Cancer. 2005 Mar 1;103(5):1018-25. doi: 10.1002/cncr.20873.
The Muir-Torre syndrome (MTS) is an autosomal-dominant genodermatosis characterized by the presence of sebaceous gland tumors, with or without keratoacanthomas, associated with visceral malignancies. A subset of patients with MTS is considered a variant of the hereditary nonpolyposis colorectal carcinoma, which is caused by mutations in mismatch-repair genes. The objective of the current study was to evaluate whether a combined clinical, immunohistochemical, and biomolecular approach could be useful for the identification of Muir-Torre syndrome among patients with a diagnosis of sebaceous tumors and keratoacanthomas.
The authors collected sebaceous skin lesions and keratoacanthomas recorded in the files of the Pathology Department of the University of Modena during the period 1986-2000. Through interviews and examination of clinical charts, family trees were drawn for 120 patients who were affected by these skin lesions.
Seven patients also were affected by gastrointestinal tumors, thus meeting the clinical criteria for the diagnosis of MTS. In the MTS families, a wide phenotypic variability was evident, both in the spectrum of visceral tumors and in the type of skin lesions. Microsatellite instability was found in five MTS patients: These patients showed concordance with immunohistochemical analysis; moreover, a constitutional mutation in the MSH2 gene was found in 1 patient. Lack of expression of MSH2/MSH6 or MLH1 proteins was evident in the skin lesions and in the associated internal malignancies of 3 patients and 2 patients with MTS, respectively.
The clinical, biomolecular, and immunohistochemical characterization of sebaceous skin lesions and keratoacanthomas may be used as screening for the identification of families at risk of MTS, a disease that is difficult to recognize and diagnose.
穆尔-托里综合征(MTS)是一种常染色体显性遗传的皮肤病,其特征为存在皮脂腺肿瘤,伴有或不伴有角化棘皮瘤,并与内脏恶性肿瘤相关。MTS患者的一个亚组被认为是遗传性非息肉病性结直肠癌的一种变异型,由错配修复基因的突变引起。本研究的目的是评估联合临床、免疫组织化学和生物分子方法是否有助于在诊断为皮脂腺肿瘤和角化棘皮瘤的患者中识别穆尔-托里综合征。
作者收集了1986年至2000年期间摩德纳大学病理科档案中记录的皮脂腺皮肤病变和角化棘皮瘤。通过访谈和查阅临床病历,为120例受这些皮肤病变影响的患者绘制了家族谱系。
7例患者还患有胃肠道肿瘤,因此符合MTS的临床诊断标准。在MTS家族中,无论是内脏肿瘤的谱系还是皮肤病变的类型,都存在明显的广泛表型变异。在5例MTS患者中发现了微卫星不稳定性:这些患者的结果与免疫组织化学分析一致;此外,在1例患者中发现了MSH2基因的一个胚系突变。在3例MTS患者的皮肤病变及相关内部恶性肿瘤中,以及在2例MTS患者中,分别明显缺乏MSH2/MSH6或MLH1蛋白的表达。
皮脂腺皮肤病变和角化棘皮瘤的临床、生物分子和免疫组织化学特征可用于筛查有MTS风险的家族,MTS是一种难以识别和诊断的疾病。